Acacia Pharma
Develops and commercializes hospital medicines for anesthesia, surgical, and oncology care teams
Highlights
- New on EvolcAdded 2026-10-29
About Acacia Pharma
Acacia Pharma Group develops and commercializes medicines for patients undergoing surgery, invasive procedures, or chemotherapy. Its portfolio includes two approved products and a late-stage candidate for chemotherapy-induced nausea and vomiting.
The company sells its products to hospital markets, commercializing its current products directly in the US through its own commercial organization, which targets anesthesia and surgical teams. It is a wholly owned subsidiary of Eagle Pharmaceuticals.
Product: Hospital medicines for nausea and vomiting and procedural sedation, plus a late-stage oncology development candidate.
Jobs at Acacia Pharma
More biotech & pharma companies
Accord Healthcare
Generic, biosimilar and added-value medicines for hospital and retail pharmacies in more than 85 countriesNew on EvolcActimed Therapeutics
Clinical-stage drug developer targeting cancer cachexia and muscle wasting with S-pindolol benzoate in Phase 2New on EvolcActual Analytics
Home-cage behaviour monitoring systems that track individual rodents in social groups for preclinical research labsNew on EvolcAds Biotec
Automated laboratory instruments, consumables and purification solutions for cytogenetic, pathology and research labsNew on EvolcAdvanz Pharma Services (UK)
Pharmaceutical company commercialising specialty, hospital and rare disease medicines and biosimilars across 90+ countriesNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- Bootstrap
- PHP
- jQuery